Venclexta (venetoclax)

pCPA File Number: 21035

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic lymphocytic leukemia (CLL), previously untreated, in adult patients who are fludarabine ineligible (in combination with obinutuzumab)

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

PC0105-000

pCPA Engagement Letter Issued:

2018-06-21

Negotiation Process Concluded:

2019-03-06